Raymond James lowered shares of CME Group (NYSE: CME) from an outperform rating to a market perform rating in a report released on Tuesday, TheFlyOnTheWall.com reports. The analysts noted that the move was a valuation call.
CME Group (NYSE: CME) traded up 0.68% on Tuesday, hitting $75.71. CME Group has a 52-week low of $49.54 and a 52-week high of $79.45. The stock’s 50-day moving average is currently $71.19. The company has a market cap of $25.279 billion and a price-to-earnings ratio of 28.81.
A number of other analysts have also recently weighed in on CME. Analysts at Sandler O’Neill raised their price target on shares of CME Group from $80.00 to $85.00 in a research note to investors on Tuesday, June 25th. They now have a buy rating on the stock. Separately, analysts at JP Morgan Cazenove upgraded shares of CME Group from an underweight rating to a market perform rating in a research note to investors on Tuesday, June 25th. They now have a GBX 72 ($1.10) price target on the stock, up previously from GBX 52.50 ($0.80). Finally, analysts at JPMorgan Chase & Co. upgraded shares of CME Group from an underweight rating to a neutral rating in a research note to investors on Tuesday, June 25th. They now have a $72.00 price target on the stock, up previously from $52.00.
One research analyst has rated the stock with a sell rating, thirteen have issued a hold rating and eight have assigned a buy rating to the stock. The stock presently has a consensus rating of Hold and an average target price of $64.05.
CME Group Inc (NYSE: CME) offers a range of global products across all asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, weather and real estate.
